Dr. Wende Kozlow, M.D.
What this data tells you about Dr. Kozlow
Dr. Wende Kozlow is an endocrinology in Sarasota, FL, with 19 years in practice. Based on federal Medicare data, Dr. Kozlow performed 64,576 Medicare services across 5,819 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kozlow received a total of $2,200 from 21 pharmaceutical and/or device companies across 54 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kozlow is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Romosozumab injection (Evenity) for osteoporosis | 34,830 | $8 | $19 |
| Denosumab injection (Prolia/Xgeva) | 21,420 | $18 | $42 |
| Office visit, established patient (30-39 min) | 1,839 | $91 | $218 |
| Blood draw (venipuncture) | 870 | $8 | $14 |
| Bone density scan (DEXA) | 834 | $36 | $201 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 797 | $26 | $89 |
| Basic metabolic blood panel | 553 | $8 | $24 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 524 | $55 | $158 |
| Hemoglobin A1c test (diabetes monitoring) | 471 | $9 | $28 |
| Thyroid stimulating hormone (TSH) test | 346 | $16 | $48 |
| Free thyroxine (T4) test | 327 | $9 | $25 |
| Urine microalbumin test (kidney screening) | 274 | $6 | $14 |
| Creatinine test (kidney function) | 274 | $5 | $14 |
| Vitamin D level test | 184 | $29 | $81 |
| New patient office visit (45-59 min) | 137 | $116 | $334 |
| Chronic care management, first 20 min/month | 120 | $47 | $86 |
| Comprehensive metabolic blood panel | 92 | $10 | $30 |
| Calcium level, total | 89 | $5 | $15 |
| Parathyroid hormone level test | 88 | $40 | $113 |
| Lipid panel (cholesterol and triglycerides) | 79 | $13 | $38 |
| Office visit, established patient (20-29 min) | 77 | $64 | $150 |
| Thyroid hormone, t3 measurement, free | 57 | $17 | $45 |
| Complete blood count (CBC) with differential | 57 | $8 | $22 |
| Kidney function blood test panel | 55 | $9 | $25 |
| Chronic care management, additional 20 min/month | 53 | $34 | $69 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 31 | $18 | $45 |
| Urinalysis with microscopic exam | 22 | $3 | $9 |
| Blood glucose (sugar) test performed by hand-held instrument | 18 | $3 | $7 |
| Iron level test | 16 | $6 | $18 |
| Vitamin B-12 level test | 14 | $15 | $43 |
| New patient office visit, complex (60-74 min) | 14 | $142 | $421 |
| Office visit, established patient, complex (40-54 min) | 14 | $135 | $294 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
3.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kozlow is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kozlow experienced with romosozumab injection (evenity) for osteoporosis?
Does Dr. Kozlow receive payments from pharmaceutical companies?
How do Dr. Kozlow's costs compare to other endocrinologys in Sarasota?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology